| Date | Time | Source | Headline | Symbol | Company |
| 05/17/2024 | 5:22PM | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders | NASDAQ:NUWE | Newellis Inc |
| 05/17/2024 | 5:20PM | Edgar (US Regulatory) | Form DEFR14A - Revised definitive proxy soliciting materials | NASDAQ:NUWE | Newellis Inc |
| 05/14/2024 | 9:00AM | GlobeNewswire Inc. | Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida | NASDAQ:NUWE | Newellis Inc |
| 05/09/2024 | 9:00AM | GlobeNewswire Inc. | Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy | NASDAQ:NUWE | Newellis Inc |
| 05/08/2024 | 5:28PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NUWE | Newellis Inc |
| 05/08/2024 | 5:26PM | Edgar (US Regulatory) | Form PRER14A - Preliminary Proxy Soliciting materials | NASDAQ:NUWE | Newellis Inc |
| 05/07/2024 | 8:00AM | GlobeNewswire Inc. | Nuwellis, Inc. Announces First Quarter 2024 Financial Results | NASDAQ:NUWE | Newellis Inc |
| 05/02/2024 | 9:00AM | GlobeNewswire Inc. | Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology | NASDAQ:NUWE | Newellis Inc |
| 04/30/2024 | 6:09PM | GlobeNewswire Inc. | Nuwellis Announces Closing of $2.7 Million Public Offering | NASDAQ:NUWE | Newellis Inc |
| 04/30/2024 | 4:41PM | GlobeNewswire Inc. | Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024 | NASDAQ:NUWE | Newellis Inc |
| 04/26/2024 | 9:17AM | GlobeNewswire Inc. | Nuwellis Announces Pricing of $2.7 Million Public Offering | NASDAQ:NUWE | Newellis Inc |
| 04/09/2024 | 9:00AM | GlobeNewswire Inc. | Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health | NASDAQ:NUWE | Newellis Inc |
| 03/11/2024 | 5:08PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:NUWE | Newellis Inc |
| 03/07/2024 | 9:08AM | GlobeNewswire Inc. | Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference | NASDAQ:NUWE | Newellis Inc |
| 03/06/2024 | 12:02PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NUWE | Newellis Inc |
| 03/05/2024 | 8:00AM | GlobeNewswire Inc. | Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:NUWE | Newellis Inc |
| 03/05/2024 | 6:05AM | IH Market News | U.S. Futures Dip, Crude Oil Fluctuates | NASDAQ:NUWE | Newellis Inc |
| 02/27/2024 | 9:00AM | GlobeNewswire Inc. | Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 | NASDAQ:NUWE | Newellis Inc |
| 02/22/2024 | 7:58AM | GlobeNewswire Inc. | Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™ | NASDAQ:NUWE | Newellis Inc |
| 02/20/2024 | 5:06PM | GlobeNewswire Inc. | Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:NUWE | Newellis Inc |
| 02/20/2024 | 8:42AM | GlobeNewswire Inc. | Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference | NASDAQ:NUWE | Newellis Inc |
| 02/08/2024 | 5:19PM | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] | NASDAQ:NUWE | Newellis Inc |
| 02/06/2024 | 9:07AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NUWE | Newellis Inc |
| 02/06/2024 | 9:00AM | GlobeNewswire Inc. | New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload | NASDAQ:NUWE | Newellis Inc |
| 01/09/2024 | 5:30PM | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:NUWE | Newellis Inc |
| 01/08/2024 | 9:24AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NUWE | Newellis Inc |
| 01/04/2024 | 4:25PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NUWE | Newellis Inc |
| 01/04/2024 | 3:05PM | GlobeNewswire Inc. | Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter | NASDAQ:NUWE | Newellis Inc |
| 12/13/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NUWE | Newellis Inc |
| 11/28/2023 | 8:00AM | GlobeNewswire Inc. | New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients | NASDAQ:NUWE | Newellis Inc |